Hillsdale Investment Management Inc. Karyopharm Therapeutics Inc. Transaction History

Hillsdale Investment Management Inc.

  • $1.13 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$14.14 - $19.71 $483,588 - $674,082
-34,200 Closed
0 $0
Q2 2020

Aug 11, 2020
SELL
$16.6 - $25.25 $16,600 - $25,250
-1,000 Reduced 2.84%
34,200 $648,000
Q1 2020

May 12, 2020
BUY
$14.38 - $27.72 $506,176 - $975,744
35,200 New
35,200 $676,000

Others Institutions Holding KPTI

# of Institutions
120
Shares Held
72.4M
Call Options Held
476K
Put Options Held
175K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $65.4M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email